よむ、つかう、まなぶ。
05【資料３】新型コロナワクチンの接種について (72 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/shingi2/0000192554_00016.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会（第29回 1／26）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
参考資料一覧(5/5)
諸外国における新型コロナワクチン追加接種の状況について
WHO
•
WHO. 2021. Coronavirus Disease (COVID-19). [online] Available at: <https://extranet.who.int/pqweb/vaccines/covid-19-vaccines> [Accessed 13 December 2021].
•
WHO. 2021. Highlights from the Meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization 4-7 October 2021 [online] Available at: <https://cdn.who.int/media/docs/defaultsource/immunization/sage/2021/october/sage_oct2021_meetinghighlights.pdf?sfvrsn=3dcae610_11> [Accessed 17 January 2022].
•
UN News. 2021. WHO advisory group recommends extra COVID-19 vaccine dose for immunocompromised. [online] Available at: <https://news.un.org/en/story/2021/10/1102732> [Accessed 5 November 2021].
•
WHO. 2021. Interim statement on booster doses for COVID-19 vaccination. [online] Available at: <https://www.who.int/news/item/04-10-2021-interim-statement-on-booster-doses-for-covid-19-vaccination> [Accessed 13 December
2021].
•
WHO. 2021. Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing. [online] Available at: <https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccinesSAGE_recommendation-BNT162b2-2021.1> [Accessed 13 December 2021].
•
WHO. 2021. Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19. [online] Available at: <https://www.who.int/publications/i/item/interim-recommendations-for-use-of-the-moderna-mrna-1273vaccine-against-covid-19> [Accessed 13 December 2021].
•
WHO. 2022. Interim statement on booster doses for COVID-19 vaccination. [online] Available at: <https://www.who.int/news/item/22-12-2021-interim-statement-on-booster-doses-for-covid-19-vaccination---update-22-december2021> [Accessed 17 January 2022].
EU
•
European Vaccination Information Portal. 2021. COVID-19 vaccines. [online] Available at: <https://vaccination-info.eu/en/covid-19/covid-19-vaccines> [Accessed 13 December 2021].
•
European Medicines Agency. 2021. Comirnaty and Spikevax: EMA recommendations on extra doses boosters - European Medicines Agency. [online] Available at: <https://www.ema.europa.eu/en/news/comirnaty-spikevax-emarecommendations-extra-doses-boosters> [Accessed 5 November2021].
•
European Medicines Agency. 2021. Spikevax: EMA recommendation on booster - European Medicines Agency. [online] Available at: <https://www.ema.europa.eu/en/news/spikevax-ema-recommendation-booster> [Accessed 13
December 2021].
•
European Medicines Agency. 2021. EMA and ECDC recommendations on heterologous vaccination courses against COVID-19 - European Medicines Agency. [online] Available at: <https://www.ema.europa.eu/en/news/ema-ecdcrecommendations-heterologous-vaccination-courses-against-covid-19> [Accessed 13 December 2021].
72
諸外国における新型コロナワクチン追加接種の状況について
WHO
•
WHO. 2021. Coronavirus Disease (COVID-19). [online] Available at: <https://extranet.who.int/pqweb/vaccines/covid-19-vaccines> [Accessed 13 December 2021].
•
WHO. 2021. Highlights from the Meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization 4-7 October 2021 [online] Available at: <https://cdn.who.int/media/docs/defaultsource/immunization/sage/2021/october/sage_oct2021_meetinghighlights.pdf?sfvrsn=3dcae610_11> [Accessed 17 January 2022].
•
UN News. 2021. WHO advisory group recommends extra COVID-19 vaccine dose for immunocompromised. [online] Available at: <https://news.un.org/en/story/2021/10/1102732> [Accessed 5 November 2021].
•
WHO. 2021. Interim statement on booster doses for COVID-19 vaccination. [online] Available at: <https://www.who.int/news/item/04-10-2021-interim-statement-on-booster-doses-for-covid-19-vaccination> [Accessed 13 December
2021].
•
WHO. 2021. Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing. [online] Available at: <https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccinesSAGE_recommendation-BNT162b2-2021.1> [Accessed 13 December 2021].
•
WHO. 2021. Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19. [online] Available at: <https://www.who.int/publications/i/item/interim-recommendations-for-use-of-the-moderna-mrna-1273vaccine-against-covid-19> [Accessed 13 December 2021].
•
WHO. 2022. Interim statement on booster doses for COVID-19 vaccination. [online] Available at: <https://www.who.int/news/item/22-12-2021-interim-statement-on-booster-doses-for-covid-19-vaccination---update-22-december2021> [Accessed 17 January 2022].
EU
•
European Vaccination Information Portal. 2021. COVID-19 vaccines. [online] Available at: <https://vaccination-info.eu/en/covid-19/covid-19-vaccines> [Accessed 13 December 2021].
•
European Medicines Agency. 2021. Comirnaty and Spikevax: EMA recommendations on extra doses boosters - European Medicines Agency. [online] Available at: <https://www.ema.europa.eu/en/news/comirnaty-spikevax-emarecommendations-extra-doses-boosters> [Accessed 5 November2021].
•
European Medicines Agency. 2021. Spikevax: EMA recommendation on booster - European Medicines Agency. [online] Available at: <https://www.ema.europa.eu/en/news/spikevax-ema-recommendation-booster> [Accessed 13
December 2021].
•
European Medicines Agency. 2021. EMA and ECDC recommendations on heterologous vaccination courses against COVID-19 - European Medicines Agency. [online] Available at: <https://www.ema.europa.eu/en/news/ema-ecdcrecommendations-heterologous-vaccination-courses-against-covid-19> [Accessed 13 December 2021].
72